PR Newswire Europe - Long-Term Benefits of Rimonabant Confirmed in Two-Year Study.
Wednesday, December 10th, 2008 NEW ORLEANS, November 9 /PRNewswire/ —
- Results From Rio-North America Trial Show That First Year Improvements in Cardiovascular Risk Factors Maintained in the Second Year of Treatment
Most Popular
When T Make Job Transfers: Good Reas…
